SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,477,148 | -44.4% | 425,691 | -25.5% | 0.01% | -40.0% |
| Q2 2023 | $2,656,977 | -13.5% | 571,393 | -14.0% | 0.02% | -21.1% |
| Q1 2023 | $3,070,457 | -43.1% | 664,601 | -0.4% | 0.02% | -47.2% |
| Q4 2022 | $5,393,207 | +30.7% | 667,476 | -10.2% | 0.04% | +9.1% |
| Q3 2022 | $4,125,000 | -22.2% | 743,228 | -26.9% | 0.03% | -19.5% |
| Q2 2022 | $5,299,000 | +3.9% | 1,017,034 | +63.9% | 0.04% | +20.6% |
| Q1 2022 | $5,100,000 | +110.2% | 620,480 | +482.2% | 0.03% | +78.9% |
| Q1 2021 | $2,426,000 | -29.0% | 106,581 | -32.2% | 0.02% | -36.7% |
| Q4 2020 | $3,415,000 | +540.7% | 157,301 | +196.7% | 0.03% | +400.0% |
| Q3 2020 | $533,000 | +9.4% | 53,013 | -15.5% | 0.01% | +20.0% |
| Q2 2020 | $487,000 | -27.1% | 62,727 | -4.3% | 0.01% | -44.4% |
| Q1 2020 | $668,000 | -7.1% | 65,531 | +0.3% | 0.01% | +28.6% |
| Q4 2019 | $719,000 | +156.8% | 65,334 | +112.2% | 0.01% | +133.3% |
| Q3 2019 | $280,000 | -43.3% | 30,786 | -29.0% | 0.00% | -57.1% |
| Q2 2019 | $494,000 | -0.4% | 43,367 | -0.4% | 0.01% | 0.0% |
| Q1 2019 | $496,000 | – | 43,526 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |